Rewriting the Neuroscience Playbook Merz Therapeutics is exploring botulinum toxin in chronic pain – a test case for unconventional thinking in neuroscience drug development By James Strachan June 23, 2026 6 min The Medicine Maker Share Summary Listen Insight Report Quiz Poll Top Institutions